DARE
Price
$2.02
Change
-$0.01 (-0.49%)
Updated
Aug 29 closing price
Capitalization
27.3M
NVCT
Price
$6.56
Change
+$0.03 (+0.46%)
Updated
Aug 29 closing price
Capitalization
167M
73 days until earnings call
Interact to see
Advertisement

DARE vs NVCT

Header iconDARE vs NVCT Comparison
Open Charts DARE vs NVCTBanner chart's image
Dare Bioscience
Price$2.02
Change-$0.01 (-0.49%)
Volume$202.11K
Capitalization27.3M
Nuvectis Pharma
Price$6.56
Change+$0.03 (+0.46%)
Volume$35.94K
Capitalization167M
DARE vs NVCT Comparison Chart in %
Loading...
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DARE vs. NVCT commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DARE is a StrongBuy and NVCT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 30, 2025
Stock price -- (DARE: $2.02 vs. NVCT: $6.56)
Brand notoriety: DARE and NVCT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DARE: 10% vs. NVCT: 19%
Market capitalization -- DARE: $27.3M vs. NVCT: $167M
DARE [@Biotechnology] is valued at $27.3M. NVCT’s [@Biotechnology] market capitalization is $167M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DARE’s FA Score shows that 0 FA rating(s) are green whileNVCT’s FA Score has 0 green FA rating(s).

  • DARE’s FA Score: 0 green, 5 red.
  • NVCT’s FA Score: 0 green, 5 red.
According to our system of comparison, NVCT is a better buy in the long-term than DARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DARE’s TA Score shows that 5 TA indicator(s) are bullish while NVCT’s TA Score has 5 bullish TA indicator(s).

  • DARE’s TA Score: 5 bullish, 3 bearish.
  • NVCT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, DARE is a better buy in the short-term than NVCT.

Price Growth

DARE (@Biotechnology) experienced а -4.72% price change this week, while NVCT (@Biotechnology) price change was -4.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.70%. For the same industry, the average monthly price growth was +20.57%, and the average quarterly price growth was +29.45%.

Reported Earning Dates

NVCT is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (-0.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVCT($167M) has a higher market cap than DARE($27.3M). NVCT YTD gains are higher at: 21.257 vs. DARE (-35.256). DARE has higher annual earnings (EBITDA): -17.84M vs. NVCT (-22.97M). NVCT has more cash in the bank: 26.8M vs. DARE (5.04M). NVCT has higher revenues than DARE: NVCT (0) vs DARE (-17.7K).
DARENVCTDARE / NVCT
Capitalization27.3M167M16%
EBITDA-17.84M-22.97M78%
Gain YTD-35.25621.257-166%
P/E Ratio0.10N/A-
Revenue-17.7K0-
Total Cash5.04M26.8M19%
Total Debt3.03MN/A-
FUNDAMENTALS RATINGS
DARE: Fundamental Ratings
DARE
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
81
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DARENVCT
RSI
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
59%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
77%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
77%
Bullish Trend 19 days ago
89%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CASXF0.06N/A
N/A
Casa Minerals Inc.
HDIUF24.93N/A
N/A
ADENTRA Inc.
LAAOF9.49N/A
N/A
Li Auto Inc.
SNTL5.47-0.01
-0.18%
Sentinel Holdings Ltd.
AFLYY1.60-0.02
-1.23%
Air France-KLM

DARE and

Correlation & Price change

A.I.dvisor indicates that over the last year, DARE has been closely correlated with AZTR. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if DARE jumps, then AZTR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DARE
1D Price
Change %
DARE100%
-0.25%
AZTR - DARE
73%
Closely correlated
+9.18%
CYTK - DARE
42%
Loosely correlated
-5.41%
AXON - DARE
39%
Loosely correlated
-4.43%
AMRN - DARE
34%
Loosely correlated
-2.37%
SNTI - DARE
32%
Poorly correlated
-5.16%
More